Steven R Deitcher insider trades: Hana Biosciences (HNAB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 31, 2007 | HNAB | ↑ Buy | 10,000 | $1.06 | $11K | Direct | Dec 31, 2007 (0d) |
| Dec 26, 2007 | HNAB | ↑ Buy | 10,000 | $1.07 | $11K | Direct | Dec 27, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Steven R Deitcher's insider trades
Steven R Deitcher is President & CEO at Hana Biosciences (HNAB). Since Dec 26, 2007, Steven has reported 2 open-market purchases worth $21K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HNAB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.